extranet

-----------------------------------------------------------

NMP-2007-1.3-3 Scientific review of the data and studies on the potential impact of engineered nano-particles on health, safety and the environment
Technical content / scope: Data on environment, safety and health effects of engineered nanoparticles need to be periodically reviewed in order to exploit the results and duly orient future research and risk management actions. In particular, a focus on nanomaterials that are likely to be produced and used in higher quantities is needed. Specific attention should be paid to carcinogenic, mutagenic or reprotoxic (CMR) properties, as well as problematic properties for the environment (like persistence or bioaccumulation). The support action(s) should collect and assess published scientific and technical data, perform a critical review to provide a state-of-the-art overview of current knowledge, produce detailed report(s) on the toxicological profiles and identify remaining uncertainties. Dynamic processes could also be considered e.g. agglomeration or de-agglomeration and other unintended reactions or interactions with surrounding media. The nanoparticles addressed with the present call are: (i) fullerene and derivates, (ii) nanotubes and derivates, (iii) metals and (iv) oxides. Conclusions should be drawn and recommendations should be issued, for research or for other initiatives.
Funding scheme: Coordination and support actions aiming at supporting research activities.
Specific features: Maximum duration: 12 months. Consortia are encouraged to be multidisciplinary, including expertise in areas of toxicology and eco-toxicology. Gender issues should be considered, where appropriate.
Expected impact: (i) Better understanding of the impact of nanoparticles on health and the environment, and definition of future actions; (ii) sustainable and responsible development.; (iii) support to research and (iv) support to regulatory measures and implementation of legislation.

MINOS-EURONET

Webmaster

***************************************************